Gene expression and biomarkers in renal transplant ischemia reperfusion injury.
The incidence of postischemic acute renal allograft failure (ARF) occurs in roughly 25% of cadaveric donor kidney recipients. This high rate remained virtually unchanged over the last decades despite modification in recipient management and modern immunosuppressive strategies. It has recently been shown that among other reasons, the systemic inflammation in the brain death cadaveric organ donor contributes to subsequent ARF in the recipient. This review focuses on the consequences of ischemia and reperfusion on the cellular level and offers potential solutions for the reduction of ARF. Genome-wide gene expression analysis together with sophisticated biostatistical analysis made it possible to identify several candidate gene products and proteins that may act as specific and sensitive biomarker for renal inflammation and ischemia. These markers may be very helpful in the clinical management of patients with a high a priori risk of subsequent ARF such as recipients of marginal donor kidneys. Ongoing clinical trials will evaluate whether immunosuppression of the cadaveric organ donor before organ harvest will have the potential to reduce inflammation in the transplant kidney and subsequently lead to a reduction in the rate of ARF.
Perco
Paul
P
Krankenhaus der Elisabethinen, Linz, Austria.
Pleban
Clara
C
Kainz
Alexander
A
Lukas
Arno
A
Mayer
Bernd
B
Oberbauer
Rainer
R
D000818:Animals; D015415:Biomarkers / Q000032:analysis; D005786:Gene Expression Regulation; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D023421:Models, Animal; D011183:Postoperative Complications; D015427:Reperfusion Injury / Q000235:genetics*
D015415:Biomarkers